Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Michigan Biologic Products Institute (MBPI) was a state-owned biopharmaceutical facility based in Lansing, Michigan, specializing in the development and manufacture of vaccines and blood products. Historically operated by the Michigan Department of Public Health, the institute was the sole producer of the Anthrax Vaccine Adsorbed (BioThrax) for the United States government. In 1998, the State of Michigan privatized the institute, selling its assets to BioPort Corporation, which subsequently became Emergent BioSolutions. MBPI's legacy continues through the ongoing production of critical biodefense vaccines at the Lansing site. The facility played a crucial role in national security by providing vaccines to the U.S. Department of Defense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Michigan Biologic Products Institute.